What are the side effects of semaglutide?
On the Wegovy label, the most common side effects of semaglutide at 2.4 mg were nausea 44 percent against 16 percent on placebo, diarrhea 30 percent, vomiting 24 percent and constipation 24 percent. Compounded semaglutide, which the FDA has not approved, costs from $59 a month at Collective (drug price, plus a yearly membership), and the Wegovy pill from NovoCare is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg, prices checked November 16, 2026.
If the monthly price is the problem, two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Check price →Eden's GLP-1 page, then an online assessment
- Check price →
Semaglutide on the weight loss label and the diabetes label
Wegovy and Ozempic both hold semaglutide from Novo Nordisk. The table puts Wegovy at 2.4 mg beside Ozempic at 1 mg, each with the placebo arm from its own trials. "Not listed" means that label prints no figure for the reaction.
| Side effect | Wegovy 2.4 mg | Wegovy placebo | Ozempic 1 mg | Ozempic placebo |
|---|---|---|---|---|
| Nausea | 44% | 16% | 20.3% | 6.1% |
| Diarrhea | 30% | 16% | 8.8% | 1.9% |
| Vomiting | 24% | 6% | 9.2% | 2.3% |
| Constipation | 24% | 11% | 3.1% | 1.5% |
| Abdominal pain (stomach pain) | 20% | 10% | 5.7% | 4.6% |
| Headache | 14% | 10% | Not listed | Not listed |
| Fatigue | 11% | 5% | Not listed | Not listed |
| Dyspepsia (indigestion) | 9% | 3% | 2.7% | 1.9% |
| Dizziness | 8% | 4% | Not listed | Not listed |
| Abdominal distension (bloating) | 7% | 5% | Not listed | Not listed |
| Eructation (burping) | 7% | <1% | 1.1% | 0% |
| Flatulence (gas) | 6% | 4% | 1.5% | 0.8% |
| Gastroenteritis (a stomach bug) | 6% | 4% | Not listed | Not listed |
| Gastroesophageal reflux disease (acid reflux) | 5% | 3% | 1.5% | 0% |
| Gastritis (an inflamed stomach lining) | 4% | 1% | 0.4% | 0.8% |
| Gastroenteritis, viral (a stomach bug from a virus) | 4% | 3% | Not listed | Not listed |
| Hair loss | 3% | 1% | Not listed | Not listed |
| Dysesthesia (altered skin sensation) | 2% | 1% | Not listed | Not listed |
Part of the gap between the columns is the clinical trials. Ozempic's were run in adults with type 2 diabetes at lower doses, and its placebo arm reported 6.1 percent nausea against 16 percent in Wegovy's. The FDA prints the same warning on both labels: rates from one drug's clinical trials cannot be compared directly with another's.
The Wegovy pill
The pill's label prints no table of its own. It says: "In the clinical trial with WEGOVY 25 mg tablets, the types and frequency of common adverse reactions were similar to those listed in Table 3." It was tested in one trial the label calls Study 7, where neither the patients nor their doctors knew who was on the drug, with 204 people on the tablet for up to 64 weeks, with a 7 week follow-up after the drug stopped. Patients with type 2 diabetes were excluded.
The label does give the pill a few figures: 6.9 percent stopped the drug for good because of a side effect, against 5.9 percent on placebo; 2 percent had a gut reaction the label calls severe, against 0; and 2.5 percent reported gallstones, against 1 percent on the placebo tablet. Wegovy pill side effects in full.
The 7.2 mg dose
Wegovy's label added a 7.2 mg dose in June 2026, tested against 2.4 mg in adults with obesity in the two clinical trials comparing the maintenance doses. Nausea went from 35 percent at 2.4 mg to 39 percent at 7.2 mg. Altered skin sensation, such as burning or tingling, went from 6 to 22 percent. Hair loss reached 6 percent at 7.2 mg.
How many people stopped
On Wegovy 2.4 mg, 6.8 percent stopped the drug over a side effect, against 3.2 percent on placebo. The reasons the label names: nausea (1.8 percent), vomiting (1.2 percent), diarrhea (0.7 percent). These reactions were most frequently reported during dosage escalation.
Comparing with tirzepatide? Tirzepatide side effects on both its labels.
Questions people ask
What are the most common side effects of semaglutide?
Stomach and gut reactions. On the Wegovy label at 2.4 mg: nausea 44 percent against 16 percent on placebo, diarrhea 30 percent, vomiting 24 percent and constipation 24 percent. Most were reported while the dose was going up.
Why does Ozempic list fewer side effects than Wegovy?
Two reasons the labels print. Ozempic's trials enrolled adults with type 2 diabetes at doses up to 1 mg, and its table lists only reactions reported by at least 5 percent of treated adults. Wegovy's table lists anything reported by at least 2 percent of treated adults and more often than placebo, in adults with obesity or overweight at 2.4 mg.
Does the Wegovy pill cause the same side effects as the shot?
The label says so: "In the clinical trial with WEGOVY 25 mg tablets, the types and frequency of common adverse reactions were similar to those listed in Table 3." It prints no separate table for the pill.
Are side effects worse at the 7.2 mg dose?
For some reactions. In the clinical trials comparing the two doses, nausea was 35 percent at 2.4 mg and 39 percent at 7.2 mg, and altered skin sensation went from 6 to 22 percent.
Is semaglutide or tirzepatide easier on the stomach?
The labels cannot settle it, because the clinical trials enrolled different people and the FDA says rates from one drug's trials cannot be compared with another's. For reference, Zepbound's label reads 28 percent nausea at 15 mg.
Do compounded semaglutide side effects match the labels?
Neither label covers a compounded product. A pharmacy makes it to a prescription and its formulation can differ, so the rates here describe the approved products only.
The rates on this page are the labels' own. Your prescriber decides what to do about a side effect. Take the label language to the appointment.
Sources
Evidence checked November 15, 2026
Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.
- Every Wegovy rate on this page: the 2.4 mg table, the 2.4 mg against 7.2 mg table, the tablet figures and the stopping figuresFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
- Every Ozempic rate, the table and the under 5 percent sentenceFDA prescribing information for Ozempic injection (DailyMed, revised June 2026)
- The FDA has not approved compounded drugs and does not review them before they are soldFDA's concerns with unapproved GLP-1 drugs used for weight loss (FDA)